FY2029 EPS Estimates for Beyond Air Lifted by Analyst

Beyond Air, Inc. (NASDAQ:XAIR) – Research analysts at Roth Capital raised their FY2029 earnings per share (EPS) estimates for Beyond Air in a report issued on Tuesday, June 17th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of $0.11 per share for the year, up from their prior estimate of $0.06. The consensus estimate for Beyond Air’s current full-year earnings is ($0.79) per share. Roth Capital also issued estimates for Beyond Air’s FY2030 earnings at $0.19 EPS.

Beyond Air Price Performance

Shares of NASDAQ:XAIR opened at $0.20 on Thursday. The business’s 50 day moving average price is $0.20 and its 200-day moving average price is $0.30. Beyond Air has a 1 year low of $0.16 and a 1 year high of $1.49. The firm has a market capitalization of $17.47 million, a price-to-earnings ratio of -0.26 and a beta of 0.23.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings results on Tuesday, June 17th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.05. Beyond Air had a negative return on equity of 213.97% and a negative net margin of 1,258.46%. The firm had revenue of $1.15 million during the quarter, compared to analyst estimates of $1.39 million.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of XAIR. XTX Topco Ltd purchased a new stake in Beyond Air during the 1st quarter worth approximately $31,000. Squarepoint Ops LLC purchased a new stake in shares of Beyond Air during the fourth quarter worth approximately $48,000. Wealthedge Investment Advisors LLC acquired a new position in Beyond Air in the 4th quarter valued at $80,000. Geode Capital Management LLC lifted its holdings in Beyond Air by 81.0% in the 4th quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock valued at $202,000 after purchasing an additional 251,823 shares in the last quarter. Finally, Kingdon Capital Management L.L.C. boosted its stake in Beyond Air by 65.0% during the 1st quarter. Kingdon Capital Management L.L.C. now owns 936,683 shares of the company’s stock worth $255,000 after purchasing an additional 369,157 shares during the last quarter. Institutional investors and hedge funds own 31.50% of the company’s stock.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.